Clinical Trial Update: Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

This clinical trial update summarizes the Phase 2 results on safety and efficacy of AGN-203818 in patients with painful diabetic neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Neuropathy

Drugs mentioned

• AGN-203818

Snippet

Sponsor: Allergan | Conditions: Diabetic Neuropathy, Painful | Phase 2 | Status: COMPLETED